RXST LEGAL NEWS: RxSight, Inc. Faces Securities Class Action after 38% Stock Drop — Contact BFA Law by September 22 Court Deadline GlobeNewswire September 16, 2025 NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against RxSight, Inc. (NASDAQ: RXST) […]

New Council Unites Leading Streaming, Data, and Technology Companies to Promote Responsible Innovation and Establish Best Practices in Automotive Streaming A coalition of industry leaders today announced the formation of the Automotive Streaming Council (ASC). This new alliance brings together executives from across the streaming media, technology, and data landscape to establish guidelines, uphold ethical

Had recent sellers known the true cost of selling a home, 75% would have made different decisions. Home sellers expect to spend $18,557 on home-selling expenses, but the actual average cost has soared to $67,245, according to a new report from Clever Offers, a platform owned by Clever Real Estate that allows home sellers on

Ascendant Loyalty Marketing, a world-renowned loyalty consulting agency, today announced a strategic partnership with inteQ, a leading provider of customer data intelligence and analytics solutions. This collaboration will introduce inteQ's Genesis Data platform to leading brands across retail, hospitality, restaurant, and e-commerce sectors, enabling them to unlock deeper customer insights and enhance their customer engagement

Body Vision Medical, a global leader in AI-powered intraoperative imaging, is proud to announce that its LungVision AI-powered advanced imaging system has received regulatory approval from the Central Drugs Standard Control Organization (CDSCO) in India. This approval marks a significant milestone in the company's mission to improve early and accurate lung cancer diagnosis worldwide. Lung

BOCA RATON, FL / ACCESS Newswire / September 16, 2025 / For a small-cap biotech, the headlines often center on fundraising, partnerships, or meeting exchange requirements. But every so often, the spotlight shifts to the science itself. Especially when it’s the kind with the potential to rewrite how cancer is treated. That is where LIXTE

No dose-limiting toxicities or cytokine release syndrome observed in RAINIER to date; mipletamig shows consistently favorable safety and tolerability Trial progressing efficiently, Cohort 4 open for enrollment SEATTLE, WA / ACCESS Newswire / September 16, 2025 / Aptevo Therapeutics ("Aptevo" or "the Company") (NASDAQ:APVO), a clinical-stage biotechnology company developing novel bispecific and trispecific immuno-oncology therapeutics,

Greene joins the leading platform for managing excess inventory with more than 15 years of sales and operations experience. BOSTON, MASSACHUSETTS / ACCESS Newswire / September 16, 2025 / Spoiler Alert, the leading platform for managing excess inventory in the CPG industry, is proud to announce Matt Greene has joined their leadership team as the

Innovative application offers transparency, restoring trust to internet conversations BOSTON, MA / ACCESS Newswire / September 16, 2025 / Plan C, LLC proudly announces the official launch of AmICredible, its groundbreaking AI-powered credibility platform. AmICredible enables individuals and organizations to easily verify the credibility of online statements before sharing, helping to reduce the rampant spread

NEW YORK, NY / ACCESS Newswire / September 16, 2025 / The Glimpse Group, Inc. ("Glimpse") (NASDAQ:VRAR), a diversified Immersive Technology platform company providing enterprise-focused Immersive Technology, Spatial Computing and Artificial Intelligence ("AI") driven software and services, today announced that is was awarded a prestigious, Small Business Technology Transfer (STTR) grant from the National Institute